CSL - Selling And Administration Expenses


CSL reported $1.23B in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Arca Biopharma USD 2.23M 1.08M Dec/2025
aTyr Pharma USD 700.63K 81.56M Mar/2026
Bio Path USD 259K 60K Mar/2026
Brainstorm Cell Therapeutics USD 1.21M 178K Mar/2026
Cara Therapeutics USD 2.09M 96K Mar/2026
CSL USD 1.23B 498M Dec/2025
Curis USD 2.96M 1.62M Mar/2026
Immunic USD 3.45M 451K Dec/2025
Minerva Neurosciences USD 2.48M 58.79K Sep/2024
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
TherapeuticsMD USD 1.23M 90K Jun/2024